Alex Olinger
Pediatric drug development is one of the most challenging areas of regulatory writing, where precision, guidance interpretation, and strategic planning are crucial to achieving regulatory success. Medical writers play a pivotal role in ensuring that regulatory submissions are clear, compliant, and robust enough to meet the unique needs of pediatric populations. In this blog, we’ll…
Read MoreAs we age, the complexity of our health often increases, leading to the management of multiple chronic conditions. This reality gives rise to a phenomenon known as polypharmacy, or the simultaneous use of multiple medications in a single patient. Polypharmacy is a significant concern, particularly among geriatric patients, where it is sometimes referred to more…
Read MoreAccording to the National Diabetes Statistics Report,1 5.7% of all United States (US) adults with type 1 diabetes rely on insulin for managing their condition. Additionally, approximately 12.3% of US adults starting using insulin within a year of their diabetes diagnosis. Insulin stands as a cornerstone in the treatment regimen, offering hope and vitality to…
Read MoreIn the ever-evolving battle against infectious diseases, the rise of drug-resistant infections poses a significant challenge to global health. These resilient bugs have developed mechanisms to withstand conventional treatments, leaving scientists and healthcare professionals searching for innovative solutions. In this blog post, we will explore the world of bug busters—the creative strategies, and the minds…
Read MoreHenrietta Lacks, an African-American woman, unknowingly contributed to one of the most significant advancements in medical science when cells taken from her cervical cancer biopsy in 1951 were used to create the first immortal human cell line, known as HeLa cells. These cells have been pivotal in numerous scientific breakthroughs, including the development of the…
Read MoreIn the ever-evolving landscape of medical research, drug repurposing has emerged as a groundbreaking approach, proving that sometimes old dogs can indeed learn new tricks. Drug repurposing, also known as drug repositioning or drug reprofiling, refers to the process of identifying new uses for existing drugs that are already approved for other indications. This approach…
Read MoreCOVID-19 began as an unexplained respiratory illness in Wuhan, China and quickly spread throughout the world, killing millions of people. Due to its longevity and the introduction of difficult new variations, medicinal therapies’ efficacy is always being tested on a global scale. The COVID-19 timeline shows the scale of the destruction this disease caused and…
Read MoreArtificial Intelligence (AI) is revolutionizing the field of cancer immunotherapy by accelerating the discovery, development, and delivery of innovative treatments. Here is a breakdown of its potential role: Drug Discovery: AI algorithms can analyze vast amounts of genomic, proteomic, and clinical data to identify potential drug targets and predict the efficacy of immunotherapies. By leveraging…
Read MoreIn today’s fast-evolving digital landscape, digital employee experience (DEx) is more than just a buzzword—it’s an essential aspect of organizational success, particularly for professionals like medical writers. DEx refers to how employees interact with the tools and technologies provided by their employer, from software applications and hardware to online services and platforms. For medical writers,…
Read MoreEntrepreneurship is often celebrated as a path to independence, innovation, and success. Last year, we highlighted the diversity and opportunity that come with starting a business. But as rewarding as entrepreneurship can be, it’s also a journey that can feel isolating at times. Whether you’re in the early stages of building your company or navigating…
Read More